GUIDANCE - Unknown Company - FDA Guidance: Content and Format of INDs for Phase 1 Studies of Drugs, Including Well-Characterized, Therapeutic, Biotechnology-Derived Products Questions and Answers: Guidance for Industry Q&A | Global Key Solutions

GUIDANCE - Unknown Company - FDA Guidance: Content and Format of INDs for Phase 1 Studies of Drugs, Including Well-Characterized, Therapeutic, Biotechnology-Derived Products Questions and Answers: Guidance for Industry Q&A | Global Key Solutions | Global Key Solutions